Filling the need for trusted information on national health issues…

Trending on kff Medicare & Medicaid at 50 Individual Market Medicaid Expansion

Private Sector Involvement

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Public Funds Majority Of Medicines R&D, Must Hold Drug Companies Accountable

Thomson Reuters Foundation: Equality, Big Pharma and lifesaving medicine John Butler, a consultant and global public health expert, and Brian Wahl, a doctoral student studying epidemiology and disease control at Johns Hopkins Bloomberg School of Public Health “…Governments and civil society must again unite behind the simple idea that everyone…

Nigeria Reinforces Commitment To Achieving MDGs

This Day Live: U.N. Envoy Pushes for More Progress on Health-related MDGs “With about 694 days to the dateline for health-related Millennium Development Goals (MDGs), the United Nations Special Envoy for Financing Health, MDGs, and Malaria, Ray Chambers, has called for [a] more concerted effort to accelerate the progress of…

Gilead To License New Hepatitis C Drug To Indian Generic Drug Manufacturers

Reuters: Gilead to license hepatitis C drug to lower-cost manufacturers in India “Gilead Sciences plans to license its breakthrough hepatitis C drug Sovaldi to a number of Indian generic pharmaceutical manufacturers, allowing for lower-priced sales of the medication in that developing nation, according to the company…” (Beasley, 2/6).

Chinese Poultry Industry’s Desire To Drop ‘Bird’ Or ‘Avian’ From Flu Reporting Is ‘Madness’

Bloomberg’s “The Ticker”: China Pretends Bird Flu Doesn’t Exist Adam Minter, a Shanghai-based contributor to Bloomberg View “…According to a Feb. 4 report by Xinhua, China’s state-owned newswire, poultry companies and associations in Guangdong province, home to a significant percentage of China’s most recent H7N9 bird flu infections, are proposing…

Cooperative Partnerships Will Help Global Community Address Cancer

Huffington Post U.K.: To Combat Cancer in Developing Countries, We Must Learn The Lessons of HIV And Malaria Allan Pamba, director of public engagement & access initiatives at GSK “…By 2020, across developing countries, more people are expected to die from cancer than from malaria, HIV and TB combined. ……

London Declaration On NTDs Showing Success

Writing in Humanosphere, development blogger Tom Paulson highlights the success of the London Declaration on Neglected Tropical Diseases. “…In the first annual progress report for the London Declaration issued last month, the authors noted the 1.12 billion NTD treatments distributed, new donor funding to help endemic countries develop integrated disease…

Developing Nations Ask For Affordable Hepatitis C Drug

New York Times: Poor Nations Seek New Hepatitis C Drug “Now that wealthy nations have a simple pill regimen that can cure hepatitis C, calls are mounting from representatives of poor nations for the same drugs…” (McNeil, 2/10).

Private-Public Partnerships Can ‘Positively Impact Health’ Worldwide

Huffington Post: Dr. Brundtland’s Impact on Global Health; We Must Stay the Course Derek Yach, executive director of the Vitality Institute “During [Dr. Gro Harlem Brundtland’s] time at WHO [as director general] and since, she has been a powerful advocate of the use of private-public partnerships to tackle many complex…

Blog Highlights Debate Around South Africa’s Delayed Patent Reforms

The Center for Global Health Policy’s “Science Speaks” blog discusses details on “Pharmagate,” a plan with the aim “to derail proposed patent reforms in South Africa, [however,] those involved indicated that the plan, dubbed ‘genocidal’ by South Africa Health Minister Aaron Motsoaledi, was the product of a misunderstanding…” (Barton, 2/11).